Home
PHAR
PHAR News

Latest Pharming Group N.V. (PHAR) News on September 12, 2025

Pharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS diagnosis

GlobeNewswire

3 months ago

Pharming Group to host webcast on findings of a new study published in Cell advancing functional classification of variants of uncertain significance (VUS) to improve APDS diagnosis

European Penny Stocks Under €200M Market Cap To Watch

Simply Wall St.

3 months ago

European Penny Stocks Under €200M Market Cap To Watch

Pharming Group reports on results of the 2025 Annual General Meeting of Shareholders

GlobeNewswire

3 months ago

Pharming Group reports on results of the 2025 Annual General Meeting of Shareholders

Pharming Group to participate in June investor conferences

GlobeNewswire

3 months ago

Pharming Group to participate in June investor conferences

European Penny Stocks To Watch In May 2025

Simply Wall St.

4 months ago

European Penny Stocks To Watch In May 2025

High Growth Tech Stocks In Europe Featuring Three Promising Picks

Simply Wall St.

4 months ago

High Growth Tech Stocks In Europe Featuring Three Promising Picks

Pharming Group First Quarter 2025 Earnings: US$0.022 loss per share (vs US$0.019 loss in 1Q 2024)

Simply Wall St.

4 months ago

Pharming Group First Quarter 2025 Earnings: US$0.022 loss per share (vs US$0.019 loss in 1Q 2024)

Pharming Group (PHGUF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth ...

GuruFocus.com

4 months ago

Pharming Group (PHGUF) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth ...

Pharming Group reports first quarter 2025 financial results and provides business update

GlobeNewswire

4 months ago

Pharming Group reports first quarter 2025 financial results and provides business update

Earnings To Watch: Pharming Group (PHGUF) Reports Q1 2025 Result

GuruFocus.com

4 months ago

Earnings To Watch: Pharming Group (PHGUF) Reports Q1 2025 Result

Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director

GlobeNewswire

4 months ago

Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director

Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)

GlobeNewswire

5 months ago

Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS)

SpringWorks Therapeutics (SWTX) Soars 9.0%: Is Further Upside Left in the Stock?

Zacks

5 months ago

SpringWorks Therapeutics (SWTX) Soars 9.0%: Is Further Upside Left in the Stock?

Pharming announces positive recommendation from NICE for Joenja

TipRanks

5 months ago

Pharming announces positive recommendation from NICE for Joenja

Pharming Group to report first quarter 2025 financial results on May 8

GlobeNewswire

5 months ago

Pharming Group to report first quarter 2025 financial results on May 8

MT Newswires

5 months ago

Pharming Group Gets Positive Recommendation in UK for Immunodeficiency Treatment

Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS

GlobeNewswire

5 months ago

Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS

European Opportunities: 3 Penny Stocks With Market Caps Larger Than €10M

Simply Wall St.

5 months ago

European Opportunities: 3 Penny Stocks With Market Caps Larger Than €10M

Exploring Three High Growth Tech Stocks In Europe

Simply Wall St.

5 months ago

Exploring Three High Growth Tech Stocks In Europe

Pharming Group announces the filing of its 2024 Annual Report and Form 20-F

GlobeNewswire

5 months ago

Pharming Group announces the filing of its 2024 Annual Report and Form 20-F

Pharming Group to participate in April investor conferences

GlobeNewswire

5 months ago

Pharming Group to participate in April investor conferences

Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation

GlobeNewswire

6 months ago

Pharming Group announces first patient dosed in Phase II clinical trial of leniolisib for common variable immunodeficiency (CVID) with immune dysregulation

Pharming Group (PHGUF) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

GuruFocus.com

6 months ago

Pharming Group (PHGUF) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

3 European Penny Stocks With Market Caps Over €300M

Simply Wall St.

6 months ago

3 European Penny Stocks With Market Caps Over €300M

Pharming Group Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.

6 months ago

Pharming Group Full Year 2024 Earnings: EPS Beats Expectations

Pharming Group reports fourth quarter and full year 2024 financial results and provides business update

GlobeNewswire

6 months ago

Pharming Group reports fourth quarter and full year 2024 financial results and provides business update

MT Newswires

6 months ago

Pharming Group Shareholders Approve Fabrice Chouraqui's Appointment as CEO

Pharming Group reports on results of the 2025 Extraordinary General Meeting of Shareholders

GlobeNewswire

6 months ago

Pharming Group reports on results of the 2025 Extraordinary General Meeting of Shareholders

Pharming Group to participate in March investor conference

GlobeNewswire

6 months ago

Pharming Group to participate in March investor conference

Pharming Group to report fourth quarter and full year 2024 financial results on March 13

GlobeNewswire

7 months ago

Pharming Group to report fourth quarter and full year 2024 financial results on March 13

Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent

GlobeNewswire

7 months ago

Pharming Technologies B.V. increases its ownership in Abliva AB (publ) to 92.70 percent

High Growth Tech And These 3 Dynamic Stocks with Promising Expansion

Simply Wall St.

7 months ago

High Growth Tech And These 3 Dynamic Stocks with Promising Expansion

Pharming Group to participate in February investor conference

GlobeNewswire

7 months ago

Pharming Group to participate in February investor conference

Pharming Technologies B.V. declares unconditional and completes the recommended cash offer to the shareholders of Abliva AB (publ) and extends the acceptance period

GlobeNewswire

7 months ago

Pharming Technologies B.V. declares unconditional and completes the recommended cash offer to the shareholders of Abliva AB (publ) and extends the acceptance period

Penny Stock Opportunities: 3 Picks With Market Caps As Low As US$20M

Simply Wall St.

7 months ago

Penny Stock Opportunities: 3 Picks With Market Caps As Low As US$20M

Pharming Group to convene Extraordinary General Meeting of Shareholders

GlobeNewswire

8 months ago

Pharming Group to convene Extraordinary General Meeting of Shareholders

MT Newswires

8 months ago

Pharming Group's Board Nominates Fabrice Chouraqui as CEO

Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer

GlobeNewswire

8 months ago

Pharming to nominate biopharmaceutical leader Fabrice Chouraqui as new Executive Director and Chief Executive Officer

3 Promising Penny Stocks With At Least US$80M Market Cap

Simply Wall St.

9 months ago

3 Promising Penny Stocks With At Least US$80M Market Cap

MT Newswires

9 months ago

Pharming Group Commences Cash Offer to Acquire Abliva for $66.1 Million

Pharming announces public cash offer to the shareholders of Abliva AB

GlobeNewswire

9 months ago

Pharming announces public cash offer to the shareholders of Abliva AB

MT Newswires

9 months ago

Pharming Reports Positive Phase III Data on Leniolisib in Children With Rare Primary Immunodeficiency; Shares Rise

European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug

Benzinga

9 months ago

European Biotech Pharming Group Touts Positive Data From Pivotal Pediatric Study Of FDA-Approved Immune System Disorder Drug

Pharming announces positive topline data in pediatric clinical trial of leniolisib

GlobeNewswire

9 months ago

Pharming announces positive topline data in pediatric clinical trial of leniolisib

MT Newswires

9 months ago

Jefferies Initiates Pharming Group at Buy With $14 Price Target

High Growth Tech Stocks To Watch For Potential Growth

Simply Wall St.

9 months ago

High Growth Tech Stocks To Watch For Potential Growth

Pharming Group And 2 Other Promising Penny Stocks To Watch

Simply Wall St.

10 months ago

Pharming Group And 2 Other Promising Penny Stocks To Watch

Pharming Group to participate in November investor conference

GlobeNewswire

10 months ago

Pharming Group to participate in November investor conference

High Growth Tech And 2 Other Promising Stocks To Watch

Simply Wall St.

10 months ago

High Growth Tech And 2 Other Promising Stocks To Watch

Pharming Group (PHGUF) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...

GuruFocus.com

a year ago

Pharming Group (PHGUF) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...

Pharming Group reports third quarter 2024 financial results and provides business update

GlobeNewswire

a year ago

Pharming Group reports third quarter 2024 financial results and provides business update

October 2024's Promising Penny Stocks to Watch

Simply Wall St.

a year ago

October 2024's Promising Penny Stocks to Watch

Pharming Group to report third quarter 2024 financial results on October 24

GlobeNewswire

a year ago

Pharming Group to report third quarter 2024 financial results on October 24

Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last?

Zacks

a year ago

Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last?

MT Newswires

a year ago

Pharming Group Gets Marketing Approval in UK for Immunodeficiency Drug

Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)

GlobeNewswire

a year ago

Pharming announces marketing authorization in the U.K. for Joenja® (leniolisib)

Pharming Group to participate in September investor conferences

GlobeNewswire

a year ago

Pharming Group to participate in September investor conferences

Pharming Group reports second quarter and first half 2024 financial results and provides business update

GlobeNewswire

a year ago

Pharming Group reports second quarter and first half 2024 financial results and provides business update

Pharming Group to report second quarter and first half 2024 financial results on August 1

GlobeNewswire

a year ago

Pharming Group to report second quarter and first half 2024 financial results on August 1

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

Yahoo Finance Video

a year ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

GlobeNewswire

a year ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit

Reuters

a year ago

California seeks company profits in Big Oil climate lawsuit

USA TODAY

a year ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

GlobeNewswire

a year ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Business Wire

a year ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Business Wire

a year ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

GlobeNewswire

a year ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Industry Report: The Cannabis Company that Soared Nearly 100% This Year: What's Behind InterCure's Surge

ACCESSWIRE

a year ago

Industry Report: The Cannabis Company that Soared Nearly 100% This Year: What's Behind InterCure's Surge

Russia is doubling down on its de-dollarization efforts as Putin calls to reduce use of 'toxic' currencies

Business Insider

a year ago

Russia is doubling down on its de-dollarization efforts as Putin calls to reduce use of 'toxic' currencies

Nvidia May Be an Exciting Stock, but Its 10-for-1 Stock Split -- Like Most Stock Splits -- Is a Nothing Burger

Motley Fool

a year ago

Nvidia May Be an Exciting Stock, but Its 10-for-1 Stock Split -- Like Most Stock Splits -- Is a Nothing Burger

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting

GlobeNewswire

a year ago

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting

Unifor members vote to strike at Manitoba Hydro

CNW Group

a year ago

Unifor members vote to strike at Manitoba Hydro

Croatia beat Portugal in Euro 2024 warm-up friendly

AFP

a year ago

Croatia beat Portugal in Euro 2024 warm-up friendly

Mark Cuban explains how he helped turn 300 of his employees into millionaires

Business Insider

a year ago

Mark Cuban explains how he helped turn 300 of his employees into millionaires

Here's what to do if you missed out on the massive 54% stock market rally since October 2022

Business Insider

a year ago

Here's what to do if you missed out on the massive 54% stock market rally since October 2022

Shareholders in Pharming Group (AMS:PHARM) are in the red if they invested a year ago

Simply Wall St.

a year ago

Shareholders in Pharming Group (AMS:PHARM) are in the red if they invested a year ago

Pharming Group to participate in June investor conferences

GlobeNewswire

a year ago

Pharming Group to participate in June investor conferences

Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union

GlobeNewswire

a year ago

Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union

Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders

GlobeNewswire

a year ago

Pharming Group reports on results of the 2024 Annual General Meeting of Shareholders

Pharming Group to participate in May investor conference

GlobeNewswire

a year ago

Pharming Group to participate in May investor conference

Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025

GlobeNewswire

a year ago

Pharming Group announces the early redemption of the remaining outstanding €125 million convertible bonds due 2025

Pharming Group reports first quarter 2024 financial results and provides business update

GlobeNewswire

a year ago

Pharming Group reports first quarter 2024 financial results and provides business update

Pharming Group to report first quarter 2024 financial results on May 8

GlobeNewswire

a year ago

Pharming Group to report first quarter 2024 financial results on May 8

Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards

GlobeNewswire

a year ago

Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards

Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?

Zacks

a year ago

Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains?

Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025

GlobeNewswire

a year ago

Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025

Pharming Group announces the placement of €100 million convertible bonds due 2029

GlobeNewswire

a year ago

Pharming Group announces the placement of €100 million convertible bonds due 2029

Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025

GlobeNewswire

a year ago

Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025

Pharming announces completion of enrollment in pediatric clinical trial of leniolisib

GlobeNewswire

a year ago

Pharming announces completion of enrollment in pediatric clinical trial of leniolisib

Pharming Group announces the 2024 Annual General Meeting of Shareholders

GlobeNewswire

a year ago

Pharming Group announces the 2024 Annual General Meeting of Shareholders

Pharming Group announces the filing of its 2023 Annual Report and Form 20-F

GlobeNewswire

a year ago

Pharming Group announces the filing of its 2023 Annual Report and Form 20-F

Pharming Group to participate in April investor conferences

GlobeNewswire

a year ago

Pharming Group to participate in April investor conferences

Pharming Group N.V. (AMS:PHARM) Analysts Are Pretty Bullish On The Stock After Recent Results

Simply Wall St.

a year ago

Pharming Group N.V. (AMS:PHARM) Analysts Are Pretty Bullish On The Stock After Recent Results

Pharming Group Full Year 2023 Earnings: US$0.015 loss per share (vs US$0.021 profit in FY 2022)

Simply Wall St.

a year ago

Pharming Group Full Year 2023 Earnings: US$0.015 loss per share (vs US$0.021 profit in FY 2022)

Pharming Group reports fourth quarter and full year 2023 financial results

GlobeNewswire

a year ago

Pharming Group reports fourth quarter and full year 2023 financial results

Pharming Group to report fourth quarter and full year 2023 financial results on March 14

GlobeNewswire

2 years ago

Pharming Group to report fourth quarter and full year 2023 financial results on March 14

Pharming Group to participate in February investor conferences

GlobeNewswire

2 years ago

Pharming Group to participate in February investor conferences

Forbes Names SP Plus Corporation to its 2024 List of America’s Most Successful Small-Cap Companies

GlobeNewswire

2 years ago

Forbes Names SP Plus Corporation to its 2024 List of America’s Most Successful Small-Cap Companies

Earnings Update: Here's Why Analysts Just Lifted Their S&T Bancorp, Inc. (NASDAQ:STBA) Price Target To US$32.50

Simply Wall St.

2 years ago

Earnings Update: Here's Why Analysts Just Lifted Their S&T Bancorp, Inc. (NASDAQ:STBA) Price Target To US$32.50

Gentex Corporation (NASDAQ:GNTX) Q4 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Gentex Corporation (NASDAQ:GNTX) Q4 2023 Earnings Call Transcript

Share on Social Networks: